EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 8

Bacopa Bacopa monnieri (L.) Wettst.

Also called: brahmi (a name also used for gotu kola), water hyssop, Herpestis monnieri (synonym)

Bacopa is a small herb of marshy, wet habitats (family Plantaginaceae) used in Ayurvedic medicine for memory. Supplements use the dried aerial parts or extracts standardized to saponins called bacosides.

Category
Botanical
Part used
Aerial parts (stems and leaves)
Strongest evidence
B Some positive trials
Native range
Native to tropical and subtropical regions worldwide (POWO/WCVP: "Tropics & Subtropics")
Reviewed
2026-10-29

Class 1 Well studied in people. A 2014 meta-analysis (J Ethnopharmacol) included 9 randomized placebo-controlled trials (518 subjects) of standardized Bacopa monnieri extracts taken without any co-medication for at least 12 weeks; 437 subjects contributed to the pooled cognition analysis. [3]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied2 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Bacopa does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Bacopa, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Attention and reaction time in adultsBA 2014 meta-analysis of nine RCTs (518 subjects; standardized extracts for 12 weeks or longer) found faster Trail B test and choice reaction times than placebo. [3]
Memory in healthy adultsBA 2026 network meta-analysis of 29 RCTs (2,107 healthy adults) reported better working memory with 600 mg/day or more than with placebo or ginkgo; it lacked direct head-to-head trials. [4]
Any disease or medical symptomCLiverTox states bacopa has not been shown to be effective for any disease or medical symptom. [2]
ADHD symptoms in children and adolescentsCA 2022 systematic review of seven RCTs of herbal products found a 'fair indication' for bacopa among others, but inadequate proof overall to support herbal medicines for ADHD. [5]

Main constituents: Dammarane-type triterpenoid saponins (bacosides, bacopasides, bacopasaponins), plus alkaloids, cucurbitacins, sterols and flavonoids [1]; The active ingredients are thought to be the saponin glycosides called bacosides [2]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • LiverTox: the typical dose is 300 to 600 mg of the extract daily. [2]
  • Pooled trials used standardized extracts for 12 weeks or longer. [3]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score E
    A: well known causeE: unlikely cause

    LiverTox likelihood score E (unlikely cause of clinically apparent liver injury) …

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    2 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • Side effects are usually minor and short-lived: abdominal pain, nausea, diarrhea, flatulence, dry mouth, headache, dizziness, insomnia and rash; adverse-event rates were similar to placebo. [2]
  • LiverTox likelihood score E: unlikely cause of clinically apparent liver injury. [2]
  • Bacopa bioaccumulates heavy metals, pesticides and other pollutants; contamination may be a bigger safety concern than adulteration. [1]
Quality

Identity, quality and standardization

  • Bacopa and gotu kola (Centella asiatica) share the name brahmi and are substituted for each other; in the most extensive study to date, 4 of 18 products contained gotu kola and 8 lacked detectable bacopa DNA. [1]
  • USP: dried bacopa must contain at least 2.5% triterpene glycosides (sum of five named saponins). TLC/HPTLC, HPLC-UV and DNA methods detect substitution. [1]
Regulation

Regulatory status

  • US: FDA states that, by law, it does not approve dietary supplements or their labeling; under DSHEA it has no authority to approve them before they are marketed, and firms are responsible for their products' safety and labeling. [6]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Bacosides (e.g., bacoside A, a mixture of four triglycosidic saponins) Saponins (dammarane-type triterpenoid) [P1]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 2 entries naming Bacopa monnieri (both combined with Rhodiola rosea) (earliest NDI 983 submitted 2017-01-30; most recent NDI 986 submitted 2017-01-31). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of bacopa (Bacopa monnieri) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]

Liver (NIH LiverTox)

  • LiverTox likelihood score E (unlikely cause of clinically apparent liver injury); not linked to serum enzyme elevations or liver injury despite wide use (chapter updated April 24, 2024). [P4]

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • BAPP bulletin (2025): bacopa is substituted with gotu kola (Centella asiatica) under the shared name brahmi; Shah et al. found 4 of 18 products adulterated with gotu kola and no bacopa DNA in 8. Detected by DNA methods, HPTLC and HPLC-UV. [P1]

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each dietary-ingredient component before use — 21 CFR 111.75(a)(1)(i) requires at least one appropriate identity test or examination unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P5]
  • HPTLC or HPLC-UV fingerprint with bacoside/bacopaside markers; DNA methods — BAPP guidance for detecting gotu kola substitution. [P1]
  • Triterpene glycoside assay (USP: not less than 2.5%) — USP monograph specification cited by BAPP. [P1]
  • Heavy metals and pesticide residues — Bacopa bioaccumulates pollutants; much is grown in rice paddies that may carry herbicide and pesticide residues. [P1]

Supply and conservation

  • In India, much bacopa is cultivated in rice paddy fields of eastern and north-eastern regions after the rice harvest. [P1]

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. Orhan N. Adulteration of bacopa (Bacopa monnieri). Botanical Adulterants Prevention Bulletin. ABC-AHP-NCNPR Botanical Adulterants Prevention Program; March 2025 (doi:10.59520/bapp.bapb/uFYe7739), 2025-03. umb.herbalgram.org
  2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  3. IARC Monographs on the Identification of Carcinogenic Hazards to Humans. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
  4. NIH LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bacopa monnieri (last update April 24, 2024), 2024-04-24. ncbi.nlm.nih.gov
  5. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, checked 2026-10-29), 2026-10-29. ecfr.gov
Sources

Sources

  1. Orhan N. Adulteration of bacopa (Bacopa monnieri). Botanical Adulterants Prevention Bulletin. ABC-AHP-NCNPR Botanical Adulterants Prevention Program; March 2025 (doi:10.59520/bapp.bapb/uFYe7739), 2025-03. umb.herbalgram.org
  2. NIH LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bacopa monnieri (last update April 24, 2024), 2024-04-24. ncbi.nlm.nih.gov
  3. Kongkeaw C, et al. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol 2014;151(1):528-535 (PMID 24252493), 2014. pubmed.ncbi.nlm.nih.gov
  4. Tiemtad P, et al. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: a systematic review and network meta-analysis. Phytomedicine 2026;153:157915 (PMID 41678913), 2026-04. pubmed.ncbi.nlm.nih.gov
  5. Dutta T, et al. Phytotherapy for attention deficit hyperactivity disorder (ADHD): a systematic review and meta-analysis. Front Pharmacol 2022;13:827411 (PMID 35592415), 2022-05-03. pubmed.ncbi.nlm.nih.gov
  6. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  7. World Checklist of Vascular Plants (WCVP, the taxonomic index to POWO; GBIF dataset f382f0ce, 2026-06-04): Bacopa monnieri (L.) Wettst., accepted, native range "Tropics & Subtropics" (retrieved 2026-10-29 via GBIF species API; POWO page could not be loaded), 2026-10-29. api.gbif.org
  8. WCVP via GBIF species API: Herpestis monnieri (L.) Rothm., synonym of Bacopa monnieri (L.) Wettst. (retrieved 2026-10-29), 2026-10-29. api.gbif.org
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.